We have identified a direct role for SMAD proteins in binding to the PAX2 gene promoter to suppress PAX2 expression in human clear cell renal cell carcinoma (CC-RCC) cells, during canonical TGF-β signalling. Here, PAX2 is linked to clear cell renal carcinoma.